Copyright Reports & Markets. All rights reserved.

Global Injectable Anthelmintic Drugs Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Benzimidazoles
    • 1.2.3 Piperazine
    • 1.2.4 Imidazothiazole
    • 1.2.5 Spiroindoles
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Injectable Anthelmintic Drugs Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
    • 1.3.5 Veterinary Pharmacies
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Injectable Anthelmintic Drugs Market Perspective (2016-2027)
  • 2.2 Injectable Anthelmintic Drugs Growth Trends by Regions
    • 2.2.1 Injectable Anthelmintic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Injectable Anthelmintic Drugs Historic Market Share by Regions (2016-2021)
    • 2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Regions (2022-2027)
  • 2.3 Injectable Anthelmintic Drugs Industry Dynamic
    • 2.3.1 Injectable Anthelmintic Drugs Market Trends
    • 2.3.2 Injectable Anthelmintic Drugs Market Drivers
    • 2.3.3 Injectable Anthelmintic Drugs Market Challenges
    • 2.3.4 Injectable Anthelmintic Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Injectable Anthelmintic Drugs Players by Revenue
    • 3.1.1 Global Top Injectable Anthelmintic Drugs Players by Revenue (2016-2021)
    • 3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2016-2021)
  • 3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Injectable Anthelmintic Drugs Revenue
  • 3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
    • 3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2020
  • 3.5 Injectable Anthelmintic Drugs Key Players Head office and Area Served
  • 3.6 Key Players Injectable Anthelmintic Drugs Product Solution and Service
  • 3.7 Date of Enter into Injectable Anthelmintic Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Anthelmintic Drugs Breakdown Data by Type

  • 4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2016-2021)
  • 4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2022-2027)

5 Injectable Anthelmintic Drugs Breakdown Data by Application

  • 5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2016-2021)
  • 5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Injectable Anthelmintic Drugs Market Size (2016-2027)
  • 6.2 North America Injectable Anthelmintic Drugs Market Size by Type
    • 6.2.1 North America Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
    • 6.2.2 North America Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
    • 6.2.3 North America Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
  • 6.3 North America Injectable Anthelmintic Drugs Market Size by Application
    • 6.3.1 North America Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
    • 6.3.2 North America Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
    • 6.3.3 North America Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
  • 6.4 North America Injectable Anthelmintic Drugs Market Size by Country
    • 6.4.1 North America Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
    • 6.4.2 North America Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Injectable Anthelmintic Drugs Market Size (2016-2027)
  • 7.2 Europe Injectable Anthelmintic Drugs Market Size by Type
    • 7.2.1 Europe Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
    • 7.2.2 Europe Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
    • 7.2.3 Europe Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
  • 7.3 Europe Injectable Anthelmintic Drugs Market Size by Application
    • 7.3.1 Europe Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
    • 7.3.2 Europe Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
    • 7.3.3 Europe Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
  • 7.4 Europe Injectable Anthelmintic Drugs Market Size by Country
    • 7.4.1 Europe Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
    • 7.4.2 Europe Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size (2016-2027)
  • 8.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Injectable Anthelmintic Drugs Market Size (2016-2027)
  • 9.2 Latin America Injectable Anthelmintic Drugs Market Size by Type
    • 9.2.1 Latin America Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
    • 9.2.2 Latin America Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
    • 9.2.3 Latin America Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
  • 9.3 Latin America Injectable Anthelmintic Drugs Market Size by Application
    • 9.3.1 Latin America Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
    • 9.3.2 Latin America Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
    • 9.3.3 Latin America Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
  • 9.4 Latin America Injectable Anthelmintic Drugs Market Size by Country
    • 9.4.1 Latin America Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
    • 9.4.2 Latin America Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size (2016-2027)
  • 10.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
    • 11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.1.5 Novartis Recent Development
  • 11.2 Cipla
    • 11.2.1 Cipla Company Details
    • 11.2.2 Cipla Business Overview
    • 11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
    • 11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.2.5 Cipla Recent Development
  • 11.3 Sun Pharmaceutical Industries
    • 11.3.1 Sun Pharmaceutical Industries Company Details
    • 11.3.2 Sun Pharmaceutical Industries Business Overview
    • 11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
    • 11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.3.5 Sun Pharmaceutical Industries Recent Development
  • 11.4 Amneal Pharmaceuticals
    • 11.4.1 Amneal Pharmaceuticals Company Details
    • 11.4.2 Amneal Pharmaceuticals Business Overview
    • 11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
    • 11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.4.5 Amneal Pharmaceuticals Recent Development
  • 11.5 Zoetis
    • 11.5.1 Zoetis Company Details
    • 11.5.2 Zoetis Business Overview
    • 11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
    • 11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.5.5 Zoetis Recent Development
  • 11.6 GlaxoSmithKline
    • 11.6.1 GlaxoSmithKline Company Details
    • 11.6.2 GlaxoSmithKline Business Overview
    • 11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
    • 11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.6.5 GlaxoSmithKline Recent Development
  • 11.7 Bayer
    • 11.7.1 Bayer Company Details
    • 11.7.2 Bayer Business Overview
    • 11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
    • 11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.7.5 Bayer Recent Development
  • 11.8 Merck
    • 11.8.1 Merck Company Details
    • 11.8.2 Merck Business Overview
    • 11.8.3 Merck Injectable Anthelmintic Drugs Introduction
    • 11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.8.5 Merck Recent Development
  • 11.9 Boehringer Ingelheim International
    • 11.9.1 Boehringer Ingelheim International Company Details
    • 11.9.2 Boehringer Ingelheim International Business Overview
    • 11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
    • 11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
    • 11.9.5 Boehringer Ingelheim International Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Injectable Anthelmintic Drugs Scope and Market Size
    Injectable Anthelmintic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Anthelmintic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Benzimidazoles
    Piperazine
    Imidazothiazole
    Spiroindoles
    Others

    Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Veterinary Pharmacies
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Novartis
    Cipla
    Sun Pharmaceutical Industries
    Amneal Pharmaceuticals
    Zoetis
    GlaxoSmithKline
    Bayer
    Merck
    Boehringer Ingelheim International

    Buy now